No abstract available
MeSH terms
-
Acetates / therapeutic use
-
Aluminum Compounds / adverse effects
-
Aluminum Compounds / pharmacokinetics
-
Aluminum Compounds / therapeutic use
-
Bone Diseases, Metabolic / chemically induced
-
Bone Diseases, Metabolic / prevention & control
-
Calcinosis / etiology
-
Calcinosis / prevention & control
-
Calcium Carbonate / adverse effects
-
Calcium Carbonate / therapeutic use
-
Calcium Compounds / therapeutic use
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control
-
Central Nervous System Diseases / chemically induced
-
Central Nervous System Diseases / prevention & control
-
Chronic Kidney Disease-Mineral and Bone Disorder / etiology
-
Chronic Kidney Disease-Mineral and Bone Disorder / prevention & control
-
Diet, Protein-Restricted
-
Ferric Compounds / therapeutic use
-
Humans
-
Hyperparathyroidism, Secondary / etiology
-
Hyperparathyroidism, Secondary / prevention & control
-
Kidney Failure, Chronic / blood*
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / diet therapy
-
Kidney Failure, Chronic / therapy
-
Lanthanum / pharmacokinetics
-
Lanthanum / therapeutic use*
-
Phosphates / blood*
-
Phosphorus, Dietary / administration & dosage
-
Phosphorus, Dietary / adverse effects
-
Phosphorus, Dietary / pharmacokinetics
-
Polyamines / pharmacokinetics
-
Polyamines / therapeutic use*
-
Renal Dialysis
-
Sevelamer
Substances
-
Acetates
-
Aluminum Compounds
-
Calcium Compounds
-
Ferric Compounds
-
Phosphates
-
Phosphorus, Dietary
-
Polyamines
-
ferric hydroxide
-
lanthanum carbonate
-
Lanthanum
-
Sevelamer
-
Calcium Carbonate
-
calcium acetate